Literature DB >> 7949117

Leukemia relapse after allogeneic bone marrow transplantation: a review.

S A Giralt1, R E Champlin.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7949117

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  12 in total

Review 1.  Filgrastim treatment of acute myelogenous leukemia (M7) relapse after allogeneic peripheral stem cell transplantation resulting in both graft-versus-leukemia effect with cytogenetic remission and chronic graft-versus-host disease manifesting as polyserositis and subsequent bronchiolitis obliterans with organizing pneumonia.

Authors:  L Law; J Tuscano; T Wun; K Ahlberg; C Richman
Journal:  Int J Hematol       Date:  2002-11       Impact factor: 2.490

2.  Second allogeneic transplantation for relapsed acute leukemia after initial allogeneic hematopoietic stem cell transplantation.

Authors:  Ryo Hanajiri; Kazuteru Ohashi; Yuka Hirashima; Kazuhiko Kakihana; Takeshi Kobayashi; Takuya Yamashita; Hisashi Sakamaki; Hideki Akiyama
Journal:  Pathol Oncol Res       Date:  2012-04-29       Impact factor: 3.201

3.  Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion.

Authors:  E J Claret; E P Alyea; E Orsini; C C Pickett; H Collins; Y Wang; D Neuberg; R J Soiffer; J Ritz
Journal:  J Clin Invest       Date:  1997-08-15       Impact factor: 14.808

4.  Granulocyte colony-stimulating factor-primed donor lymphocyte infusion after salvage chemotherapy for treatment of relapsed acute leukemia after allogeneic stem cell transplantation.

Authors:  Takeshi Kobayashi; Kazuteru Ohashi; Miwa Sakai; Takuya Yamashita; Yoshiki Okuyama; Kiyoshi Hiruma; Hideki Akiyama; Hisashi Sakamaki
Journal:  Int J Hematol       Date:  2005-07       Impact factor: 2.490

Review 5.  Review of stem-cell transplantation for myelodysplastic syndromes in older patients in the context of the Decision Memo for Allogeneic Hematopoietic Stem Cell Transplantation for Myelodysplastic Syndrome emanating from the Centers for Medicare and Medicaid Services.

Authors:  Sergio A Giralt; Mary Horowitz; Daniel Weisdorf; Corey Cutler
Journal:  J Clin Oncol       Date:  2011-01-10       Impact factor: 44.544

6.  Second allogeneic hematopoietic stem cell transplantation for leukemia relapse after first allogeneic transplantation: outcome of 16 patients in a single institution.

Authors:  Akira Tomonari; Tohru Iseki; Jun Ooi; Hitomi Nagayama; Hiroyuki Sato; Tsutomu Takahashi; Kiyoshi Ito; Fumitaka Nagamura; Kaoru Uchimaru; Satoshi Takahashi; Naoki Shirafuji; Arinobu Tojo; Kenzaburo Tani; Shigetaka Asano
Journal:  Int J Hematol       Date:  2002-04       Impact factor: 2.490

7.  Treatment strategies in patients with AML or high-risk myelodysplastic syndrome relapsed after Allo-SCT.

Authors:  T Sauer; G Silling; C Groth; F Rosenow; U Krug; D Görlich; G Evers; J Albring; R Besoke; R M Mesters; C Müller-Tidow; T Kessler; T Büchner; W E Berdel; M Stelljes
Journal:  Bone Marrow Transplant       Date:  2015-01-19       Impact factor: 5.483

8.  Extramedullary relapse of acute myeloid leukemia following allogeneic hematopoietic stem cell transplantation: incidence, risk factors and outcomes.

Authors:  Andrew C Harris; Carrie L Kitko; Daniel R Couriel; Thomas M Braun; Sung W Choi; John Magenau; Shin Mineishi; Attaphol Pawarode; Gregory Yanik; John E Levine
Journal:  Haematologica       Date:  2012-10-12       Impact factor: 9.941

9.  Conjugation of haematopoietic stem cells and platelets decorated with anti-PD-1 antibodies augments anti-leukaemia efficacy.

Authors:  Quanyin Hu; Wujin Sun; Jinqiang Wang; Huitong Ruan; Xudong Zhang; Yanqi Ye; Song Shen; Chao Wang; Weiyue Lu; Ke Cheng; Gianpietro Dotti; Joshua F Zeidner; Jun Wang; Zhen Gu
Journal:  Nat Biomed Eng       Date:  2018-10-29       Impact factor: 25.671

10.  Lipid from infective L. donovani regulates acute myeloid cell growth via mitochondria dependent MAPK pathway.

Authors:  Nabanita Chatterjee; Subhadip Das; Dipayan Bose; Somenath Banerjee; Tarun Jha; Krishna Das Saha
Journal:  PLoS One       Date:  2015-03-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.